RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/DD64A83DF43E2162DE3C8C062E59A8A9676BFDE6F8FDFDA343FFECFEFA07CA77B9D5BB58DDC71410F723ED9D10279A4Bhttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/DD64A83DF43E2162DE3C8C062E59A8A9676BFDE6F8FDFDA343FFECFEFA07CA77B9D5BB58DDC71410F723ED9D10279A4Bhttp://www.w3.org/2000/01/rdf-schema#comment"p21-associated inhibition of early-stage malignant progression and the intense expression in papilloma outgrowths identifies a novel significant antagonism between p21 and ras(Ha)/ROCK2/NF-kappaB signalling in skin carcinogenesis.these data show that ROCK2 activation induces malignancy in ras(Ha)-initiated/promoted papillomas in the context of p53 loss and novel NF-kappaB expression"xsd:string
http://purl.uniprot.org/uniprot/#_CA2D94F493B245AA6BD70247F25BB4BF3E3DC5EBA9A11E3D9CAE8286888C392071C22E6F5CEBE997D1C29A46AC170B44http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/DD64A83DF43E2162DE3C8C062E59A8A9676BFDE6F8FDFDA343FFECFEFA07CA77B9D5BB58DDC71410F723ED9D10279A4B
http://purl.uniprot.org/uniprot/F8VPK5http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/DD64A83DF43E2162DE3C8C062E59A8A9676BFDE6F8FDFDA343FFECFEFA07CA77B9D5BB58DDC71410F723ED9D10279A4B
http://purl.uniprot.org/uniprot/#_F8VPK5-mappedCitation-27991921http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/DD64A83DF43E2162DE3C8C062E59A8A9676BFDE6F8FDFDA343FFECFEFA07CA77B9D5BB58DDC71410F723ED9D10279A4B